Zantac cancer lawsuits are for being filed for patients diagnosed with certain types of cancer after using Zantac (ranitidine) for heartburn associated with acid indigestion and sour stomach. According to medical research, some of the cancers associated with Zantac use due to NDMA exposure … More
Main Navigation Menu
➤ Pharmaceutical Drug Injury Lawsuits
➤ Asbestos and Mesothelioma Claims
➤ Benzene Diseases and Cancers Claims
➤ GenX Water Contamination Cancer Cases
➤ Breast Implants Lymphoma Cancer Cases
➤ Free Case Evaluation by Lawyer Tom Lamb
➤ About the Law Offices of Thomas J. Lamb
➤ Frequently Asked Questions (FAQs)
➤ Medical Records Copying Cost Laws
➤ Client Resources: Legal, Medical, and More
➤ Collection of Articles by Our Law Firm
Please know that you can use our Quick Contact Form to tell us a bit about your case.
Recent Articles
Radical hemithoracic radiotherapy doubles survival among certain patients with mesothelioma
Patients with malignant pleural mesothelioma who underwent nonradical surgery and chemotherapy appeared twice as likely to achieve 2-year OS with radical hemithoracic radiotherapy vs. palliative radiotherapy, according to randomized phase 3 study results presented at European Society for … More
FDA Proposes New Recommendations for Breast Implant Labels
The FDA has come up with a draft guidance list of labeling changes that they recommend be made by breast implant manufacturers to address the safety concerns threatening women all over the world. The recent October 2019 article from The New York Times, “Women Should Be Warned of Breast Implant … More
Cancer in the classroom
[Lea DiRusso was exposed to asbestos while teaching at schools for nearly 30 years, then this teacher is diagnosed with mesothelioma.] Every week during the school year, teacher Lea DiRusso climbed on a chair and hung her students’ best work on a clothesline strung between two old heating pipes. … More
Lemtrada Safety Issues Lead To Use Restrictions In Europe
Drug safety regulators for the European Union recently recommended that Lemtrada use be restricted to certain limited patient populations due to serious side effects linked to Lemtrada. This November 5, 2019 Multiple Sclerosis News Today report, “EMA Safety Group Advises Lemtrada Be … More
Disappointment Over Immunotherapy in Mesothelioma
Despite showing promise in phase 2 trials, new results from a randomized phase 3 [ immunotherapy in mesothelioma ] trial are disappointing in a tumor type that remains a major killer. In patients with malignant pleural mesothelioma (MPM) who had progressed after first-line chemotherapy, … More